Table 4 Association of antibiotic therapy with outcomes in patients with VA-LRTI
VAT | Before propensity scores matching | After propensity scores matching | ||||
|---|---|---|---|---|---|---|
IAAT | AAT | P value | IAAT | AAT | P value | |
Low PA | ||||||
 No. of patients | 33 | 26 |  | 22 | 22 |  |
 VFDs at 28 days, median (IQR) | 24 (0–27) | 22 (14–25) | 0.37 | 24 (0–26) | 23 (12–25) | 0.85 |
 ICU mortality | 1 (3%) | 3 (11.5%) | 0.2 | 1 (4.6%) | 3 (13.6%) | 0.61 |
Moderate PA | ||||||
 No. of patients | 49 | 47 |  | 35 | 35 |  |
 VFDs at 28 days, median (IQR) | 22 (0–27) | 21 (0–25) | 0.44 | 23 (0–27) | 21 (0–25) | 0.38 |
 ICU mortality | 3 (6.1%) | 9 (19.2%) | 0.054 | 2 (5.7%) | 6 (17.1%) | 0.26 |
High PA | ||||||
 No. of patients | 33 | 48 |  | 25 | 25 |  |
 VFDs at 28 days, median (IQR) | 0 (0–20) | 19 (0–24) | 0.02 | 0 (0–22) | 17 (0–22) | 0.06 |
 ICU mortality | 9 (27.3%) | 8 (16.7%) | 0.25 | 9 (36%) | 6 (24%) | 0.54 |
VAP | IAAT | AAT | P value | |||
|---|---|---|---|---|---|---|
Low PA | ||||||
 No. of patients | 11 | 5 |  | |||
 VFDs at 28 days, median (IQR) | 13 (0–22) | 9 (5–19) | 1 | |||
ICU mortality | 5 (45.5%) | 0 | 0.07 | |||
Moderate PA | ||||||
 No. of patients | 13 | 6 |  | |||
 VFDs at 28 days, median (IQR) | 0 (0–19) | 0 (0–23) | 0.8 | |||
 ICU mortality | 6 (46.2%) | 1 (16.7%) | 0.22 | |||
High PA | ||||||
 No. of patients | 23 | 12 |  | |||
 VFDs at 28 days, median (IQR) | 0 (0–0) | 0 (0–13) | 0.41 | |||
 ICU mortality | 11 (47.8%) | 5 (41.7%) | 0.73 | |||